Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 47 , ISSUE 1 ( January-March, 2013 ) > List of Articles

REVIEW ARTICLE

Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment

Vishal Sharma, Surinder Singh Rana, Deepak Kumar Bhasin

Citation Information : Sharma V, Rana SS, Bhasin DK. Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment. J Postgrad Med Edu Res 2013; 47 (1):54-60.

DOI: 10.5005/jp-journals-10028-1056

Published Online: 00-03-2013

Copyright Statement:  Copyright © 2013; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Rana SS, Sharma V, Bhasin DK. Role of Endoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors and Update on Their Treatment. J Postgrad Med Edu Res 2013;47(1):54-60.


PDF Share
  1. Updated population-based review of carcinoid tumors. Ann Surg 2004;240:117-22.
  2. One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063-72.
  3. Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors. Gut Liver 2012;6:405-10.
  4. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 2012;61:6-32.
  5. Preoperative detection of gastrointestinal neuroendocrine tumors using endoscopic ultrasonography. Rev Esp Enferm Dig 2006;98:828-36.
  6. The role of endoscopic ultrasonography in the diagnosis and management of pancreatic cancer. Gastroenterol Clin North Am 2012;41:179-88.
  7. Levels of evidence in endoscopic ultrasonography: A systematic review. Dig Dis Sci 2012;57:602-09.
  8. EUS for pancreatic neuroendocrine tumors: A single-center, 11-year experience. Gastrointest Endosc 2010;71:1185-93.
  9. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography and angiography. Gastroenterology 1992;102:188-99.
  10. Localization of islet cell tumors by endoscopic ultrasonography. Gastroenterology 1992;103:711-12.
  11. Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging. Radiology 1994;190:745-51.
  12. Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: A single-centre retrospective study. Clin Nucl Med 2010;35:321-28.
  13. Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound 1999;10:139-50.
  14. EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia. Gastrointest Endosc 2003;58:531-35.
  15. Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. Ultrasound Med Biol 2008;34:525-32.
  16. Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors. Gastrointest Endosc 2010;71:951-59.
  17. Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine 2007;31:238-41.
  18. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: A study of 48 cases. Cancer 2008;114:255-62.
  19. The role of cytomorphology and proliferative activity in predicting biologic behavior of pancreatic neuroendocrine tumors: A study by endoscopic ultrasound-guided fine-needle aspiration cytology. Cancer 2009;117:211-16.
  20. Carcinoid tumors of the gastrointestinal tract: Evaluation with endoscopic ultrasonography. Gastrointest Endosc 1993;39:375-83.
  21. Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography. Dis Colon Rectum 2005;48:285-91.
  22. Endoscopic ultrasound-assisted endoscopic resection of carcinoid tumors of the gastrointestinal tract. Rev Esp Enferm Dig 2004;96:847-55.
  23. Usefulness of endoscopic submucosal dissection for the treatment of rectal carcinoid tumors. Eur J Gastroenterol Hepatol 2012;24:770-74.
  24. Endoscopic submucosal dissection for rectal carcinoid tumors. Surg Endosc 2010;24:504-08.
  25. Review of the pathogenesis, diagnosis, and management of type I gastric carcinoid tumor. World J Surg 2011;35:1879-86.
  26. Gastric carcinoids: Between underestimation and overtreatment. World J Gastroenterol 2009;15:2177-83.
  27. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma. Clin Endocrinol (Oxf) 2002;56:557-59.
  28. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 2006;63:1059-62.
  29. Endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma. Endoscopy 2011;43(Suppl 2)UCTN:E328-29.
  30. Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma. Acta Gastroenterol Belg 2008;71:333-37.
  31. Treatment of a pancreatic endocrine tumor by ethanol injection (PEI) guided by endoscopic ultrasound. Endoscopy 2008 Sep;40(Suppl 2):E83.
  32. US-guided ethanol ablation of insulinomas: A new treatment option. Gastrointest Endosc 2012;75:200-06.
  33. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61-72.
  34. Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors. J Chir (Paris) 2005;142:132-49.
  35. Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 2006;7:150-56.
  36. Surgery on neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007;21:87-109.
  37. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am 2001;81:511-25.
  38. Neuroendocrine tumors. J Natl Compr Canc Netw 2012;10:724-64.
  39. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook. Ann Oncol 1999;10(Suppl 2):S31-38.
  40. Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: A prospective study in 39 patients. Gut 1996;39:279-83.
  41. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001;12(Suppl 2):S111-14.
  42. Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours. Eur J Cancer 1992;28A:1647-50.
  43. Combination therapy with octreotide and alphainterferon: Effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 1999; 94:1381-87.
  44. Eastern Cooperative Oncology G. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol 2005;23:4897-904.
  45. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999; 81:1351-55.
  46. Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Pract Res Clin Endocrinol Metab 2007;21:163-72.
  47. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364: 514-23.
  48. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011;364:501-13.
  49. Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol 2008;26:1316-23.
  50. Neuroendocrine tumors. Peptide receptor radionuclide therapy. Best Pract Res Clin Endocrinol Metab 2007;21:111-29.
  51. Treatment of neuroendocrine tumor liver metastases. Int J Hepatol 2012:973-946.
  52. Liver transplantation for metastatic neuroendocrine carcinoma: An analysis of 103 patients. Transplantation 1998;66: 1307-12.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.